Literature DB >> 15239965

Sustained muscle sympathetic activity after hypercapnic but not hypocapnic hypoxia in normal humans.

Renaud Tamisier1, Luz Nieto, Amit Anand, David Cunnington, J Woodrow Weiss.   

Abstract

Exposure to hypercapnic hypoxia (asphyxia), but not hyperoxic hypercapnia, results in increased sympathetic activity that persists after exposure. To determine the contribution of CO2 to the post-hypoxia sympathoexcitation, we exposed 12 normal volunteers to hypocapnic and hypercapnic hypoxia (SaO2 approximately 85%) for 20 min each on different days. We measured plethysmographic forearm blood flow, muscle sympathetic nerve activity (MSNA), mean arterial pressure (MAP), and heart rate. MSNA increased during both exposures but remained elevated for 15 min only after asphyxia. Following asphyxia, MAP returned to pre-exposure values, but after hypocapnic hypoxia MAP decreased below baseline for 15 min. There were sustained decreases in heart rate after hypocapnic, but not hypercapnic hypoxia. Forearm vascular resistance (FVR) decreased below baseline during both exposures, reached its highest value above baseline after asphyxia and then declined. After hypocapnic hypoxia FVR rose to baseline after exposure. Hemodynamics are differently altered by hypercapnic relative to hypocapnic 20 min hypoxia, while only hypercapnic hypoxia produces sustained elevation of MSNA during recovery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15239965     DOI: 10.1016/j.resp.2004.04.006

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  13 in total

Review 1.  Apneic Sleep, Insufficient Sleep, and Hypertension.

Authors:  Meghna P Mansukhani; Naima Covassin; Virend K Somers
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

2.  Long-term intermittent hypoxia increases sympathetic activity and chemosensitivity during acute hypoxia in humans.

Authors:  Sarah-Jane C Lusina; Paul M Kennedy; J Timothy Inglis; Donald C McKenzie; Najib T Ayas; A William Sheel
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

3.  Effects of continuous positive airway pressure and isocapnic-hypoxia on cerebral autoregulation in patients with obstructive sleep apnoea.

Authors:  Xavier Waltz; Andrew E Beaudin; Patrick J Hanly; Georgios D Mitsis; Marc J Poulin
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

4.  Effect of repetitive hypoxic apnoeas on baroreflex function in humans.

Authors:  Kevin D Monahan; Urs A Leuenberger; Chester A Ray
Journal:  J Physiol       Date:  2006-05-18       Impact factor: 5.182

Review 5.  OSA and Cardiac Arrhythmogenesis: Mechanistic Insights.

Authors:  Anna M May; David R Van Wagoner; Reena Mehra
Journal:  Chest       Date:  2016-09-29       Impact factor: 9.410

Review 6.  Sympathoadrenal mechanisms in the pathogenesis of sleep apnea-related hypertension.

Authors:  Oded Friedman; Alexander G Logan
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 7.  Chemoreflexes, sleep apnea, and sympathetic dysregulation.

Authors:  Meghna P Mansukhani; Tomas Kara; Sean M Caples; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

8.  Sympathetic withdrawal augments cerebral blood flow during acute hypercapnia in sleeping lambs.

Authors:  Priscila A Cassaglia; Robert I Griffiths; Adrian M Walker
Journal:  Sleep       Date:  2008-12       Impact factor: 5.849

9.  Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans.

Authors:  Glen E Foster; Julien V Brugniaux; Vincent Pialoux; Cailean T C Duggan; Patrick J Hanly; Sofia B Ahmed; Marc J Poulin
Journal:  J Physiol       Date:  2009-05-05       Impact factor: 5.182

10.  Hyperoxia attenuates muscle sympathetic nerve activity following isocapnic hypoxia in humans.

Authors:  Jordan S Querido; Paul M Kennedy; A William Sheel
Journal:  J Appl Physiol (1985)       Date:  2010-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.